CCL22 and hepatocellular carcinoma: For instance, in HCC patients, elevated TGF-β activity associated with the persistent presence of hepatitis B virus (HBV) in the liver tissue, and was shown to downregulate miR-34a expression; this led to the enhanced production of the chemokine CCL22, which recruited regulatory T cells to facilitate immune escape.